Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rheumatologisches Versorgungszentrum Steglitz (RVZ Steglitz) is a specialized outpatient medical center located in Berlin, Germany, dedicated to the diagnosis and treatment of inflammatory rheumatic and musculoskeletal diseases. The center provides comprehensive care for a broad spectrum of autoimmune conditions, including rheumatoid arthritis, spondyloarthritis, and connective tissue diseases. In addition to its clinical practice, RVZ Steglitz operates as a significant clinical research hub, participating as a study site for international Phase 2 and Phase 3 clinical trials. The facility integrates advanced diagnostic capabilities, such as high-resolution musculoskeletal ultrasound and specialized laboratory services, to facilitate personalized therapeutic strategies. By combining expert medical consultation with access to innovative investigational therapies, the center serves as a key provider in the regional healthcare landscape for rheumatology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rheumatology Care Center Steglitz.